{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Orally administrable modified-release pharmaceutical dosage form", "item": "https://www.patentleaderboard.com/patent/11344519"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Orally administrable modified-release pharmaceutical dosage form

Orally administrable modified-release pharmaceutical dosage form

US Patent 11344519 · Granted May 31, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tablet comprising modoflaner as an active component2025
MASP inhibitory compounds and uses thereof2025
Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dime2025
Photochemical process for producing (4R,4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy2025
Process for producing acyloxymethyl esters of (4S)-(4-cyano-2-methoxyphenyl)-5-e2025
Synthesis of 4-amino-5-methyl-1H-pyridin-2(1H)-on (intermediate compound for the2025
Method for preparing 2-[(3R)-3-methylmorpholin-4-yl]-4-[1-methyl-1H-pyrazol-5-yl2025
Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trif2025
Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trif2025
Treatment of cardiopulmonary disorders2024
Treatment of cardiopulmonary disorders2024
Substituted 5-fluoro-1H-pyrazolopyridines and their use2024